leadf
logo-loader
ASX:KZA NASDAQ:KZIA

Kazia Therapeutics Ltd

Receive alerts
Market:
ASX
Market Cap:
$129.63 m
Price
1.37 AUD
Change
3.79%
52 weeks high
1.78
52 weeks low
0.35

In brief

Kazia Therapeutics (ASX: KZA, NASDAQ: KZIA) pipeline includes two clinical-stage drug development candidates.

Snapshot

During the September quarter the company’s Paxalisib drug was granted special designations by US FDA, Rare Pediatric Disease Designation in DIPG, Orphan Designation in glioma, and Fast Track Designation in glioblastoma.